Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ENTA
Recent news which mentions ENTA
< Previous
1
2
3
4
Next >
A small biotech says Pfizer infringed on its patent with Paxlovid
June 22, 2022
Tickers
ABBV
ENTA
PFE
SPX
Tags
SPX
PFE
ENTA
From
MarketWatch
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Tickers
APLS
ATHA
BMRN
CBIO
Tags
FDA
ATHA
IBB
From
Benzinga
Expert Ratings for Enanta Pharmaceuticals
June 01, 2022
Tickers
ENTA
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022
June 01, 2022
Tickers
AOMR
BPMC
CF
CTT
Tags
STTK
Intraday Update
Benzinga
From
Benzinga
The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
May 19, 2022
Tickers
ADMP
ENTA
EVO
IBB
Tags
General
Market News
COVID/19 Coronavirus
From
Benzinga
Enanta Pharmaceuticals Shares Fall After RSVP Phase 2b study results Miss Primary Endpoint
May 18, 2022
Tickers
ENTA
Tags
Market News
Small Cap
General
From
Benzinga
10 Biggest Price Target Changes For Tuesday
May 10, 2022
Tickers
AMGN
ANNX
BURL
ENTA
Tags
ICUI
Penny Stocks
BURL
From
Benzinga
Enanta Pharmaceuticals (ENTA) Q2 2022 Earnings Call Transcript
May 10, 2022
Tickers
ENTA
Tags
ENTA
Recent Press Releases
Market News
From
Motley Fool
Enanta Pharma Commences Dosing In Phase 1 COVID-19 Trial
February 16, 2022
Tickers
ENTA
Tags
Small Cap
Benzinga
Health Care
From
Benzinga
Where Enanta Pharmaceuticals Stands With Analysts
February 09, 2022
Tickers
ENTA
Tags
BZI/AAR
Market News
Analyst Ratings
From
Benzinga
Enanta Pharmaceuticals (ENTA) Q1 2022 Earnings Call Transcript
February 09, 2022
Tickers
ENTA
Tags
ENTA
Recent Press Releases
Market News
From
Motley Fool
Enanta Pharmaceuticals: Q1 Earnings Insights
February 08, 2022
Tickers
ENTA
Tags
Benzinga
BZI/Recaps
ENTA
From
Benzinga
Earnings Scheduled For February 8, 2022
February 08, 2022
Tickers
AAT
ABST
AGCO
AIZ
Tags
DCPH
HUBG
MN
From
Benzinga
What 10 Analyst Ratings Have To Say About Enanta Pharmaceuticals
January 13, 2022
Tickers
ENTA
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
10 Biggest Price Target Changes For Thursday
January 13, 2022
Tickers
AVB
BIIB
CHGG
COP
Tags
Market News
Price Target
Leisure Products
From
Benzinga
7 A-Rated Biotechs to Buy for the Long Run
December 03, 2021
Tickers
BCYC
BNTX
CDMO
ENTA
Tags
Stocks to Buy
BNTX
NASDAQ:BCYC,NASDAQ:BNTX,NASDAQ:CDMO,NASDAQ:ENTA,NASDAQ:ISEE,NASDAQ:MRNA,NASDAQ:PRTA,NYSE:PFE
From
InvestorPlace
Where Enanta Pharmaceuticals Stands With Analysts
November 24, 2021
Tickers
ENTA
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
56 Biggest Movers From Yesterday
November 24, 2021
Tickers
ADMP
ANF
APVO
ARMP
Tags
Movers
ZM
Pre/Market Outlook
From
Benzinga
Enanta Pharmaceuticals, inc (ENTA) Q4 2021 Earnings Call Transcript
November 22, 2021
Tickers
ENTA
Tags
Market News
Recent Press Releases
ENTA
From
Motley Fool
52 Biggest Movers From Friday
November 22, 2021
Tickers
AHI
AKYA
AMAT
AMSWA
Tags
TUSK
AMAT
AKYA
From
Benzinga
Earnings Scheduled For November 22, 2021
November 22, 2021
Tickers
A
ADMP
AESE
AFYA
Tags
Benzinga
KEYS
ENTA
From
Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
Tickers
AADI
ABEO
ADMP
APLT
Tags
LIAN
Earnings
CNTG
From
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 19, 2021
Tickers
AKYA
AQB
ATHX
AWH
Tags
Intraday Update
SESN
Benzinga
From
Benzinga
Enanta Pharmaceuticals's Earnings: A Preview
November 19, 2021
Tickers
ENTA
Tags
ENTA
Benzinga
BZI/EP
From
Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
Tickers
ASND
BMY
CADL
CNTB
Tags
Benzinga
MRK
RETA
From
Benzinga
Safety Signals Force Enanta To Stop EDP-721 HBV Program
November 19, 2021
Tickers
ENTA
Tags
Briefs
ENTA
Biotech
From
Benzinga
Expert Ratings For Enanta Pharmaceuticals
November 08, 2021
Tickers
ENTA
Tags
BZI/AAR
Market News
Analyst Ratings
From
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
RETA
Benzinga
PFE
From
Benzinga
10 Biggest Price Target Changes For Monday
November 08, 2021
Tickers
CAKE
CGNX
CRNX
DCPH
Tags
Price Target
FROG
Price Target Changes
From
Benzinga
Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’
November 05, 2021
Tickers
AVIR
ENTA
MRK
PFE
Tags
SPX
AVIR
PFE
From
MarketWatch
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.